SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 84 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $29,000 | +3.6% | 52,822 | +0.2% | 0.00% | – |
| Q1 2016 | $28,000 | -50.9% | 52,730 | -17.6% | 0.00% | – |
| Q4 2015 | $57,000 | -41.2% | 63,982 | -46.4% | 0.00% | – |
| Q3 2015 | $97,000 | -94.3% | 119,335 | -78.9% | 0.00% | -100.0% |
| Q2 2015 | $1,704,000 | +82.4% | 566,120 | +48.5% | 0.00% | – |
| Q1 2015 | $934,000 | +195.6% | 381,237 | +207.8% | 0.00% | – |
| Q4 2014 | $316,000 | -93.0% | 123,876 | -80.4% | 0.00% | -100.0% |
| Q3 2014 | $4,520,000 | +3431.2% | 632,971 | +3116.8% | 0.00% | – |
| Q2 2014 | $128,000 | -73.3% | 19,677 | -72.8% | 0.00% | – |
| Q1 2014 | $479,000 | -61.9% | 72,472 | -72.7% | 0.00% | – |
| Q4 2013 | $1,257,000 | +1032.4% | 265,182 | +1087.0% | 0.00% | – |
| Q3 2013 | $111,000 | +42.3% | 22,340 | +48.8% | 0.00% | – |
| Q2 2013 | $78,000 | -79.8% | 15,015 | -83.7% | 0.00% | – |
| Q4 2012 | $386,000 | +160.8% | 91,840 | +247.9% | 0.00% | – |
| Q3 2012 | $148,000 | – | 26,396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 3,500,000 | $8,576,000 | 1.54% |
| GREAT POINT PARTNERS LLC | 1,038,652 | $2,545,000 | 1.12% |
| BVF INC/IL | 1,893,030 | $4,638,000 | 0.97% |
| Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
| Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,300,000 | $3,185,000 | 0.33% |
| DSC Advisors, L.P. | 225,000 | $551,000 | 0.29% |
| Perceptive Advisors | 700,000 | $1,715,000 | 0.13% |
| DSC Advisors, L.P. | 400,000 | $240,000 | 0.13% |
| Endurant Capital Management LP | 140,000 | $343,000 | 0.11% |